Rice Hall James & Associates’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,022
Closed -$278K 278
2022
Q1
$278K Hold
3,022
0.01% 280
2021
Q4
$306K Hold
3,022
0.01% 280
2021
Q3
$294K Hold
3,022
0.01% 282
2021
Q2
$312K Hold
3,022
0.01% 279
2021
Q1
$269K Buy
+3,022
New +$280K 0.01% 286

Other funds holding CRI

Rice Hall James & Associates's CRI Position: Q2 2022 in Review

Rice Hall James & Associates sold out of Carter's (CRI) in Q2 2022, closing a stake of 3,022 shares — an estimated $278K sold.

Rice Hall James & Associates first reported a position in CRI in Q1 2021 and held it in 5 quarters. The position peaked at $312K in Q2 2021. 315 funds tracked by Wall St. Rank hold CRI as of Q2 2022.

  • Rice Hall James & Associates reported no remaining Carter's position as of Q2 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 3,022 Carter's shares in Q2 2022, an estimated $278K.
  • Rice Hall James & Associates first reported a position in Carter's in Q1 2021 and held it in 5 quarters.
  • Rice Hall James & Associates's Carter's position peaked at $312K in Q2 2021.
  • 315 funds tracked by Wall St. Rank held Carter's as of Q2 2022.

Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.